Jennifer Seminerio, MD


Take-Home Messages for the Management of Crohn’s Disease

Experts in gastroenterology share advice for the treatment of patients of Crohn’s disease.

Benjamin Natelson, MD


Prospective Advancements and Final Thoughts on the Treatment of FM

Experts conclude their discussion emphasizing the importance of integrative care and how providers can improve outcomes for their patients with fibromyalgia (FM).

Maia Kayal, MD


Key Takeaways and Prospective Treatment Advances

David Hudesman, MD, Maia Kayal, MD, Miguel Regueiro, MD, Anita Afzali, MD, and Millie Long summarize their discussion of Inflammatory Bowel Disease (IBD) and discuss prospective advances in treatment options.

Steve R. Ommen, MD


Patient Education of HCM

Expert cardiologists share strategies for educating patients on the treatment and management of hypertrophic cardiomyopathy.

Sophia Humphreys, PharmD, MHA


The Role of Pharmacy Benefit Managers and Payers in Accessing Adalimumab Biosimilars

A clinical pharmacist discusses the role of pharmacy benefit managers and payers in accessibility of adalimumab biosimilars.

Hassieb Din, MD


Does Aggressive or Moderate Fluid Resuscitation Better Treat Acute Pancreatitis?

A recent randomized controlled trial showed the limitations of either option, despite being a cornerstone of care.

Andrew Iwach, MD


Managing Glaucoma During COVID-19: Patients Point the Way to Improved Care

A new survey assessed patients’ confidence in their disease management during the pandemic, specific disease management concerns, and experiences with telemedicine.

Rakesh Jain, MD, MPH, Texas Tech University School of Medicine


Optimizing Care for ADHD During COVID-19

Optimizing care and managing challenges for patients with ADHD during the COVID-19 pandemic and advice for clinicians educating patients and families on disease management.

Jennifer Lim, MD, FARVO, FASRS


Faricimab Versus High-Dose Aflibercept for the Treatment of Neovascular AMD and DME

Retina specialists evaluate the effectiveness of the two new therapies for neovascular AMD and DME by analyzing their respective clinical trial methodologies and outcomes.

Andrew L. Concoff, MD, FACR, CAQSM


Introducing the Concoff Method: The Interface Between Sports Medicine and Rheumatology

In today's issue of Rheumatology Network, we introduce The Concoff Method, a new column by Andrew Concoff, M.D., a rheumatologist who serves as executive vice president and chief value medical officer of United Rheumatology. Over the course of the next year, Dr. Concoff will publish columns that address sports medicine, value in rheumatology and managing a medical practice in the era of COVID-19. In this inaugural issue of the column, he covers the interface between sports medicine and rheumatology.

Miguel Regueiro, MD


Selecting CD Treatment in Special Scenarios

Experts in gastroenterology discuss treatment selection in special situations of CD, such as age, women considering pregnancy, and extra-intestinal manifestations.

Jeremy Adler, DMSc, PA-C, DFAAPA, Pacific Pain Medicine Consultants


Final Thoughts on the Opioid Crisis and Normalizing Naloxone

The multidisciplinary panel of experts share final thoughts on strategies to normalize naloxone and decrease barriers to its obtainment and utilization.

Paul Doghramji, MD, FAAFP


Dual-Orexin Receptor Antagonists for Treatment of Insomnia

In an upcoming Peer Exchange program entitled “Dual-Orexin Receptor Antagonists for Treatment of Insomnia” Dr Paul Doghramji will moderate a conversation with physicians about this class of agents for treatment of insomnia and discuss other therapeutic advancements in the field.

Fernando J. Martinez, MD, MS


Clinical Pearls for the Management of IPF

Steven D. Nathan, MD, FCCP, and Fernando J. Martinez, MD, MS, share clinical pearls and advice for the management of IPF.

Amy Brennan


Patient-Specific Characteristics Driving AD Treatment Regimen

Drs Keegan and Cameron discuss patient-specific considerations for selecting optimal atopic dermatitis treatment strategies.

Matthew M. Heeney, MD


Practice Pearls for the Management of SCD

A panel of experts in hematology discuss the future directions for sickle cell disease and share practice pearls for disease management.

Margaret Bobonich, DNP, FNP-C, DCNP, FAANP


Care Collaboration in Atopic Dermatitis

Experts in dermatology discuss patient education and clinical pearls to assist colleagues in the management of atopic dermatitis.

Cindy Steinberg


Assessing the Draft Revised CDC Clinical Practice Guideline for Prescribing Opioids 2022

The Director of Policy and Advocacy for the US Pain Foundation addresses the important changes made to the updated draft of the CDC Clinical Practical Guideline for Prescribing Opioids 2022.

Andrew Blauvelt, MD


Switching Therapies in AD

Andrew Blauvelt, MD, discusses switching therapies for atopic dermatitis (AD) treatment.

Jose Scher, MD


Concurrent Management of Inflammatory Bowel Disease and Psoriatic Arthritis

Dr David Hudesman, Dr Jordan Axelrad, and Dr Jose Scher discuss strategies for managing coexisting inflammatory bowel disease and psoriatic arthritis and highlight the importance of a multidisciplinary approach to providing comprehensive care.

Nina Cosdon


FDA Approves RSV Vaccine for Older Adults

The approval for Abrysvo represents the second RSV vaccine approved for adults aged 60 years and older in the last month.

Anthony Rossi, MD


Empowering Patients: Navigating the Progression Risks of Actinic Keratosis and Optimizing Treatment Selection

In this episode of MEDcast, expert dermatologists discuss actinic keratosis, a premalignant skin condition. They are sharing their thoughts on the importance of early diagnosis and treatment and are delving into treatment options, in particular photodynamic treatments.

Isabella Ciccone, MPH


Stigma in Epilepsy in 2023: How Far Have We Come?

In recent conversations with experts in epilepsy, the impact of stigmatization remains high for patients and ongoing efforts by clinicians to address this issue in the clinical setting has been underscored, despite the global lack of awareness about new treatments and other resources.

Jennifer Soung, MD


Unraveling Boxed Warnings: Exploring/Examining Risks in Biologic Treatment Classes

Experts highlight how a history of cancer may impact psoriasis treatment decisions while touching on the safety profiles of newer IL agents.

Emily Sims, MD


Challenges in Managing Type 1 Diabetes and Pressing Need for New Therapies

Drs Diana Isaacs and Natalie Bellini discuss the everyday challenges of managing type 1 diabetes and underscore the need for new treatments to improve the quality of life for people living with type 1 diabetes

© 2024 MJH Life Sciences

All rights reserved.